Clin2
NCT07641361Possibly a fitRecruiting

Staying Hydrated to Feel Better on GLP-1 Medication

Obesity & OverweightType 2 DiabetesType 2 Diabetes (Adult Onset)Obesity Type 2 Diabetes MellitusDehydration

Part of Hormones & metabolism clinical trials.

This study tests whether drinking more water helps reduce uncomfortable side effects (like nausea and vomiting) when you first start taking GLP-1 medications for weight loss or diabetes. You'll be asked to follow a hydration plan and report how you feel.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old
  • You started a GLP-1 medication (like Ozempic, Wegovy, or Mounjaro) within the last week
  • You speak and read English fluently
  • You can commit to completing the full study and following the hydration plan
  • You are not pregnant and do not plan to become pregnant during the study
  • You do not have a pacemaker or other cardiac implant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07179107Recruiting
Staying hydrated for better health

This study looks at whether drinking enough water can improve your health. You'll need to be available at the same time for 8 weeks in a row.

Phoenix, Arizona
NCT07770906Not yet recruiting
Effect of GLP-1 medications on gum disease treatment

This study looks at whether taking GLP-1 medications (commonly used for diabetes or weight loss) can improve gum health and the response to standard non-surgical gum disease treatment. If you are on a GLP-1 drug and have gum disease, this trial may help determine if your treatment works better.

NCT07743567Recruiting
Weight and pregnancy outcomes after GLP-1 use

This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.

Kansas City, Kansas
NCT07835360Recruiting
Body changes after starting GLP-1 medications for weight or diabetes

This study looks at how your body composition (muscle and fat) changes after you start a GLP-1 medication for obesity or type 2 diabetes. You will be followed for a year with body scans to see the effects.

Mexico City, Mexico City
NCT07701460Not yet recruiting
What happens after stopping glp-1 weight-loss medication

This study follows people who recently stopped taking a GLP-1 medication to see how their eating habits, daily routines, and weight change over time. It aims to learn how to better support people after they stop, helping them maintain a healthy weight.

Boston, Massachusetts
NCT07089732Not yet recruiting
GLP-1 drink for blood sugar and gut health

This trial tests a special drink that may help improve blood sugar levels and gut health in people with prediabetes. It could offer a simple way to manage blood sugar and potentially prevent diabetes.

Taichung, South

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.